Skip to main content

Table 1 Characteristics of subjects

From: Association and predictive value analysis for metabolic syndrome on systolic and diastolic heart failure in high-risk patients

Variable

Total (n = 347)

Reference (n = 124)

DHF (n = 97)

SHF (n = 126)

P value

Age

57.18 ± 12.94

48.36 ± 12.34

60.28 ± 10.87

63.48 ± 9.93

<0.001

Gender (Female, %)

139 (40.06%)

52 (41.94%)

39 (40.21%)

48 (38.1%)

0.662

BMI

23.80 ± 3.88

22.93 ± 3.28

24.22 ± 3.44

24.35 ± 4.57

0.007

WC

82.64 ± 7.82

78.97 ± 6.21

82.91 ± 7.18

86.04 ± 7.09

<0.001

SBP

127.42 ± 19.01

120.12 ± 14.57

134.46 ± 20.75

129.24 ± 19.17

<0.001

DBP

77.59 ± 11.47

75.07 ± 10.17

80.63 ± 12.84

77.73 ± 11.07

0.002

HR

74.77 ± 14.51

70.84 ± 10.75

74.4 ± 13.91

79.65 ± 17.24

<0.001

Laboratory assay

     

FPG

6.23 ± 2.46

5.80 ± 2.63

6.38 ± 2.71

6.54 ± 1.99

0.047

PBG

8.92 ± 4.35

8.27 ± 4.54

9.36 ± 4.28

9.04 ± 4.28

0.402

HbAlc

6.81 ± 1.99

6.73 ± 2.55

6.96 ± 2.13

6.75 ± 1.44

0.805

TC

4.46 ± 1.08

4.44 ± 1.16

4.59 ± 1.08

4.39 ± 0.98

0.373

TG

1.70 ± 1.37

1.53 ± 1.20

1.87 ± 1.35

1.74 ± 1.54

0.176

HDL

1.09 ± 0.29

1.17 ± 0.31

1.09 ± 0.28

1.00 ± 0.26

<0.001

LDL

2.58 ± 0.87

2.5 ± 0.91

2.64 ± 0.89

2.62 ± 0.8

0.445

SCr

80.31 ± 39.9

68.74 ± 14.72

74.71 ± 16.48

100.4 ± 42.1

<0.001

Ccr

86.56 ± 31.82

101.08 ± 26.41

86.86 ± 25.59

71.31 ± 34.35

<0.001

UA

0.36 ± 0.12

0.32 ± 0.08

0.36 ± 0.12

0.4 ± 0.13

<0.001

Echocardiography

     

LAD

38.13 ± 6.24

33.85 ± 3.4

37.44 ± 5.05

42.91 ± 5.95

<0.001

LVMI

126.83 ± 48.78

98.47 ± 25.21

118.08 ± 40.75

161.89 ± 51.01

<0.001

EF

55.53 ± 14.50

65.55 ± 5.22

65.68 ± 6.39

38.00 ± 5.77

<0.001

DT

203.92 ± 54.74

189.19 ± 23.19

231.82 ± 69.73

163.86 ± 50.97

<0.001

Medical history

     

HT (yes, %)

247 (71.18%)

57 (45.97%)

73 (75.26%)

117 (92.86%)

<0.001

DM (yes, %)

166 (49.26%)

36 (29.03%)

53 (54.64%)

77 (61.11%)

<0.001

MetS (yes, %)

92 (26.51%)

16 (12.9%)

30 (30.93%)

46 (36.51%)

<0.001

CAD (yes, %)

86 (24.78%)

24 (19.35%)

26 (26.8%)

36 (28.57%)

0.208

Smoking (yes, %)

123 (38.2%)

40 (32.26%)

27 (27.84%)

56 (44.44%)

<0.001

Medical therapy

     

Anti-HT

232 (66.86%)

52 (41.94%)

39 (40.21%)

48 (38.1%)

<0.001

Anti-DM

119 (35.74%)

27 (21.77%)

43 (44.33%)

49 (38.89%)

<0.001

Anti-HF

89 (25.65%)

1 (0.81%)

10 (10.31%)

78 (61.9%)

<0.001

Anti-Lip

113 (33.73%)

28 (22.58%)

23 (23.71%)

62 (49.21%)

<0.001

  1. Note: BMI- Body mass index, WC- waist circumference, SBP- systolic blood pressure, DBP- diastolic blood pressure, MetS- metabolic syndrome, HT- Hypertension, DM- Diabetes, FPG- fasting plasma glucose, PBG- plasma blood glucose, HbA1c- glycated hemoglobin, TC- serum total cholesterol, HDL- high-density lipoprotein cholesterol, TG- triglyceride, UA- uric acid, LDL- low density lipoprotein cholesterol, Ccr- creatinine clearance rate, Cr- creatinine, LVMI- left ventricular mass index, LAD- left atrial diameter, DT- deceleration time, LVEF- left ventricular ejection fraction, HF- heart failure.
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us